HI SB639

Reclassifies pseudoephedrine as a Schedule V controlled substance effective July 1, 2013, requiring a written prescription for dispensing.

Exempts cold products containing pseudoephedrine in combination with other active ingredients from the prescription requirement if the amount does not exceed 3.6 grams per day or 9 grams per 30-day period.

Requires pharmacies to maintain written or electronic logs of all pseudoephedrine purchases, including customer identification, transaction details, and signatures for a period of five years.

Allows pharmacists to dispense pseudoephedrine without a prescription only when combined with other active ingredients in cold products and within the specified daily and monthly limits.

Aims to reduce methamphetamine lab incidents by controlling access to pseudoephedrine, following models implemented in Oregon and Mississippi.